Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Correction to: One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?

Heiland DH, Haaker G, Watzlawick R, Delev D, Masalha W, Franco P, Machein M, Staszewski O, Oelhke O, Nicolay NH, Schnell O.

J Neurooncol. 2018 Nov;140(2):393. doi: 10.1007/s11060-018-2994-2.

PMID:
30203165
2.

One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?

Heiland DH, Haaker G, Watzlawick R, Delev D, Masalha W, Franco P, Machein M, Staszewski O, Oelhke O, Nicolay NH, Schnell O.

J Neurooncol. 2018 Nov;140(2):385-391. doi: 10.1007/s11060-018-2964-8. Epub 2018 Aug 3. Erratum in: J Neurooncol. 2018 Sep 10;:.

PMID:
30076585
3.

Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.

Osterberg N, Ferrara N, Vacher J, Gaedicke S, Niedermann G, Weyerbrock A, Doostkam S, Schaefer HE, Plate KH, Machein MR.

Neuro Oncol. 2016 Jul;18(7):939-49. doi: 10.1093/neuonc/now005. Epub 2016 Mar 6.

4.

Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas.

Roelz R, Reinacher P, Jabbarli R, Kraeutle R, Hippchen B, Egger K, Weyerbrock A, Machein M.

Sci Rep. 2015 Dec 4;5:17758. doi: 10.1038/srep17758.

5.

Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.

Baumgarten P, Blank AE, Franz K, Hattingen E, Dunst M, Zeiner P, Hoffmann K, Bähr O, Mäder L, Goeppert B, Machein M, Seifert V, Steinbach JP, Plate KH, Harter PN, Mittelbronn M.

Neuro Oncol. 2016 Feb;18(2):173-83. doi: 10.1093/neuonc/nov288. Epub 2015 Nov 30.

6.

Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine.

Heiland DH, Masalha W, Franco P, Machein MR, Weyerbrock A.

J Neurooncol. 2016 Feb;126(3):567-75. doi: 10.1007/s11060-015-2002-z. Epub 2015 Nov 27.

PMID:
26614518
7.

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells.

Prasad S, Gaedicke S, Machein M, Mittler G, Braun F, Hettich M, Firat E, Klingner K, Schüler J, Wider D, Wäsch RM, Herold-Mende C, Elsässer-Beile U, Niedermann G.

Cancer Res. 2015 Jun 1;75(11):2166-76. doi: 10.1158/0008-5472.CAN-14-2415. Epub 2015 Apr 3.

8.

Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas.

Schneider K, Weyerbrock A, Doostkam S, Plate K, Machein MR.

J Neurooncol. 2015 Jan;121(2):269-78. doi: 10.1007/s11060-014-1647-3. Epub 2014 Nov 5.

PMID:
25370707
9.

Bone marrow chimera experiments to determine the contribution of hematopoietic stem cells to cerebral angiogenesis.

Machein MR, Plate KH.

Methods Mol Biol. 2014;1135:275-88. doi: 10.1007/978-1-4939-0320-7_23.

PMID:
24510872
10.

Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells.

Gaedicke S, Braun F, Prasad S, Machein M, Firat E, Hettich M, Gudihal R, Zhu X, Klingner K, Schüler J, Herold-Mende CC, Grosu AL, Behe M, Weber W, Mäcke H, Niedermann G.

Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):E692-701. doi: 10.1073/pnas.1314189111. Epub 2014 Jan 27.

11.

Intraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours.

Reithmeier T, Lopez WO, Doostkam S, Machein MR, Pinsker MO, Trippel M, Nikkhah G.

Clin Neurol Neurosurg. 2013 Oct;115(10):1955-60. doi: 10.1016/j.clineuro.2013.05.019. Epub 2013 Jun 14.

PMID:
23769864
12.

VEGFR-1 signaling regulates the homing of bone marrow-derived cells in a mouse stroke model.

Beck H, Raab S, Copanaki E, Heil M, Scholz A, Shibuya M, Deller T, Machein M, Plate KH.

J Neuropathol Exp Neurol. 2010 Feb;69(2):168-75. doi: 10.1097/NEN.0b013e3181c9c05b.

PMID:
20084017
13.

Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.

Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR.

Int J Cancer. 2009 Oct 15;125(8):1771-7. doi: 10.1002/ijc.24605.

14.

Angiogenesis in gliomas.

Machein M, de Miguel LS.

Recent Results Cancer Res. 2009;171:193-215. doi: 10.1007/978-3-540-31206-2_12. Review.

PMID:
19322546
15.

Flt-1 signaling in macrophages promotes glioma growth in vivo.

Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M, Plate KH, Machein MR.

Cancer Res. 2008 Sep 15;68(18):7342-51. doi: 10.1158/0008-5472.CAN-07-6241.

16.

The role of angiopoietins during angiogenesis in gliomas.

Reiss Y, Machein MR, Plate KH.

Brain Pathol. 2005 Oct;15(4):311-7. Review.

PMID:
16389943
17.

Endothelial cell transplantation for gene therapy in experimental gliomas.

Machein MR, Knoth R, Plate KH.

Neurosurgery. 2005 Dec;57(6):1264-71; discussion 1264-71.

PMID:
16331175
18.

Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model.

Machein MR, Knedla A, Knoth R, Wagner S, Neuschl E, Plate KH.

Am J Pathol. 2004 Nov;165(5):1557-70.

19.

Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants.

Heidenreich R, Machein M, Nicolaus A, Hilbig A, Wild C, Clauss M, Plate KH, Breier G.

Int J Cancer. 2004 Sep 1;111(3):348-57.

20.

Role of VEGF in developmental angiogenesis and in tumor angiogenesis in the brain.

Machein MR, Plate KH.

Cancer Treat Res. 2004;117:191-218. Review. No abstract available.

PMID:
15015562
21.
22.

Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas.

Machein MR, Renninger S, de Lima-Hahn E, Plate KH.

Brain Pathol. 2003 Oct;13(4):582-97.

PMID:
14655762
23.

VEGF in brain tumors.

Machein MR, Plate KH.

J Neurooncol. 2000 Oct-Nov;50(1-2):109-20. Review.

PMID:
11245271
24.

Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.

Donnini S, Machein MR, Plate KH, Weich HA.

J Pathol. 1999 Sep;189(1):66-71.

PMID:
10451490
25.
26.

Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells.

Machein MR, Kullmer J, Rönicke V, Machein U, Krieg M, Damert A, Breier G, Risau W, Plate KH.

Neuropathol Appl Neurobiol. 1999 Apr;25(2):104-12.

PMID:
10215998
27.

Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors.

Machein MR, Kullmer J, Fiebich BL, Plate KH, Warnke PC.

Neurosurgery. 1999 Apr;44(4):732-40; discussion 740-1.

PMID:
10201297
28.

Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.

Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B.

Am J Pathol. 1998 Aug;153(2):429-37.

29.

Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.

Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH.

Cancer Res. 1997 Sep 1;57(17):3860-4.

30.

Anti-angiogenic gene therapy of malignant glioma.

Stratmann A, Machein MR, Plate KH.

Acta Neurochir Suppl. 1997;68:105-10. Review.

PMID:
9233424

Supplemental Content

Loading ...
Support Center